Conference
Efficacy of targeted therapy (TT) after checkpoint inhibitors (CPI) in metastatic renal cell carcinoma (mRCC): Results from the Canadian Kidney Cancer Information System (CKCis).
Abstract
568
Background: While the use of CPI has demonstrated clinical benefit in patients with mRCC, data showing the efficacy of subsequent TT is limited. This real-world analysis evaluated the efficacy of TT post CPI in mRCC patients. Methods: Data was collected and analyzed from CKCis. Patients with mRCC who received TT after CPI were identified and analyzed based on line of therapy. Time to treatment failure (TTF – time from …
Authors
Kalirai A; Wood L; Lalani A-KA; Heng DYC; Ghosh S; Iafolla MAJ; Kollmannsberger CK; Soulieres D; Castonguay V; Bossé D
Volume
37
Pagination
pp. 568-568
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2019
DOI
10.1200/jco.2019.37.7_suppl.568
Conference proceedings
Journal of Clinical Oncology
Issue
7_suppl
ISSN
0732-183X